Seek guidance from a healthcare professional who can provide personalized assistance. With the right mindset and approach, you can quit smoking and enjoy a healthier, smoke-free life.

Read how psychological symptoms can accompany thyroid disorders and possible treatment and management options

Hormonal acne is most common in people between the ages of 20 and 50. It often appears as inflamed bumps or cysts on the chin, jawline, or other areas on the lower part of the face.

Smoking is a slow death that is damaging your health day by day, but quitting can transform your life. It is one of the leading causes of preventable diseases across the world, and it raises the risk of lung cancer, cardiovascular diseases, stroke, and respiratory diseases. Quitting smoking can be difficult, but it is possible if approached with the proper strategy.

For such a small gland, the thyroid has a huge influence on both our physical and psychological wellbeing. It affects everything from our heart rate, metabolism, circulation and bone health. It even influences how we think and feel!

Under normal circumstances, if the level drops just a little below normal, the pituitary reacts by releasing a hormone called the Thyroid-Stimulating Hormone, also known as TSH, and this hormone activates the thyroid gland to produce more T4 and T3.

Transdermal buprenorphine (Butrans and generic) is FDA-approved for treating pain. It does not require an XDEA number or training to prescribe. The transdermal form is a good alternative for patients who have developed tolerance to other opioids, had a benefit from opioid treatment but wish to get more info escalate treatment, and are taking ≤ 80 MME/day. Start with a 5 or 10 mcg patch (changed weekly), and discontinue other opioids.

Remember the facts: Smoking can kill you. And think about how much better you’ll feel once smoking is out of your life.

Prescribers must follow state and federal legal requirements when prescribing opioids and other controlled substances.

The most serious potential adverse effect is respiratory depression accompanied by symptoms of sedation and confusion. It may occur with high dose administration in opioid naïve patients. Opioids, at therapeutic doses, depress respiratory rate and tidal volume.

Initiation of sublingual buprenorphine can provoke acute opioid withdrawal if not done correctly. Therefore, only prescribers trained in its use and in possession of an XDEA number (or working under guidance of such a prescriber) should initiate sublingual buprenorphine/naloxone. Once a patient is on it and stable, primary prescribers may take over chronic management.

Organize office procedures to meet prescribing requirements. See patients who are on a stable Schedule II-III opioid regimen every 2-3 months. Send in prescriptions to last until the next scheduled appointment or beyond to permit pill counts. For example, on one date, electronically send two 4-week prescriptions and specify a future fill date on one of the prescriptions. For patients taking a Schedule II opioid who are seen every 3 months, utilize clinic personnel to monitor prescription dispensing.

Longer duration affects dose titration. Methadone has a prolonged terminal half-life, so the degree of potential adverse effects can increase over several days after an initial dose or a change of dosage.

A clear plan raises your chances of success. One of the most effective methods is going cold turkey, which means quitting abruptly. While it can be challenging, studies suggest it works better than a gradual reduction. Choose a day, prepare yourself mentally, and make that commitment.